Results No operative mortality and morbidity occurred.
结果无手术死亡和并发症。
The operative mortality reported in the literature was 40%.
手术死亡率文献报导达40%。
Results Of the 26 patients, 8 died after operation(operative mortality was 30.8%).
结果26例患者手术后死亡8例，手术死亡率30.8%。
Results the patients were successfully through the perioperative period, no operative mortality.
结果本组患者均顺利度过围手术期，无一例手术死亡。
Result: No recurrence of tumor has been found with transcranial approach, and the operative mortality was 0.8%.
结果：经颅手术术后无一例复发，手术死亡2例(0.8%)：经蝶切除肿瘤者。
The actual operative mortality rates were 2.4% in metabolic syndrome patients and 0.9% in patients without metabolic syndrome.
真正的手术死亡率在代谢综合症的病人中为2.4%，无代谢综合症的病人为0.9%。
Pneumonectomy for non-small cell lung cancer carries an acceptable operative mortality and provides an important survival benefit.
因非小细胞肺癌而接受全肺切除术有可接受的手术死亡率并且能提供重要的生存益处。
Results: There was no operative mortality and severe complication in all patients. The light node metastasis occurred in 11 (52%) patients.
结果：全组无手术死亡及严重并发症发生，有11例(52%)患者存在淋巴结转移。
The early and late operative mortality was 33.33 % and 6.4 % respectively with the difference between them being statistically significant.
早期手术与延期手术的死亡率分别为33.33%和6 .4 % ，二者差异具有显著意义；
If EVAR is to replace open aneurysm repair in the future, it must be achieved lower peri-operative mortality and better long-term outcomes.
如果腹主动脉瘤腔内修复术欲在未来完全取代传统手术，降低围手术期死亡率并提高长期疗效势在必行。
Results The second operations were successfully completed in 24 cases, cervical anastomotic leakage happened in 1 case and no operative mortality.
结果24例成功地完成二次手术，1例出现颈部吻合口瘘，无手术死亡。
Conclusion Our study showed that combined multiple organ resection for patients with AGC can be performed with relatively low operative mortality and acceptable morbidity.
结论多脏器联合切除术治疗进展期胃癌手术死亡率较低，并发症发生率是可接受的。
Objective To study the clinical features of acoustic neurinomas, and discuss the improvement of surgically preserving of facial nerve function and reducing the operative mortality.
目的总结听神经瘤显微手术的特点，提高面神经保留率，减少并发症和降低死亡率。
Conversions to thoracotomy was needed in 24 cases (8.1%). Postoperative complications were seen in 37 cases (12.4%), and fatal complications in 2 cases. There were no operative mortality.
中转开胸完成手术24例(8.1%)，手术并发症37例(12.4%)，其中手术后死亡2例，无术中死亡。
Objective to review the experience of the combined coronary artery bypass grafting (CABG) and cardiac valve operations to improve the operative effects and decrease the operative mortality.
目的为了提高同期施行冠状动脉旁路移植术(CABG)与心瓣膜手术的疗效，降低死亡率，总结手术及围术期处理的经验。
Conclusion: PTCD plays an important role in diagnosing and treating the old ACST patient and it can improve the operative effects and decrease the mortality rate.
结论：PTCD对老年acst的诊断与治疗有重要意义，可明显提高手术治疗效果及降低死亡率。
Results: No any operative complication or mortality occurred in these patients.
结果：无手术并发症及手术死亡发生。
Conclusions the key points to decrease the morbidity and mortality of pancreaticoduodenectomy are delicate operative maneuver and effective perioperative treatment.
结论降低胰十二指肠切除术后并发症及死亡率的关键在于外科手术操作的精细及积极的围术期处理。
Methods We studied the operative indication, the incidence and mortality of operative complication of early phase (24 cases) and delayed phase(26 cases)groups.
方法对比分析了早期手术组（2 4例）和延期手术组（2 6例）的手术适应症、并发症发生率和死亡率。
Results All the 9 patients underwent operative treatment with no mortality. 6 cases were treated by CMPAMNS and 3 cases treated by CMPAMRA.
结果9例病人均行手术治疗，无手术死亡，其中经改良翼点入路开颅显微手术治疗6例，经改良翼点入路开颅射频辅助显微手术治疗3例。
Conclusion: Using hypoglycemia drugs methodically during perioperative time to control the blood sugar can reduce operative complication and mortality.
结论：对糖尿病者围手术期合理采用降糖药，严格控制血糖，同样能减少并发症和死亡率，达到预期外科治疗效果。
Is Pre-operative Anaemia a Risk Marker for In-hospital Mortality and Morbidity After Valve Replacement?
手术前贫血是瓣膜置换手术后院内死亡率和发病率的危险标记物吗？
The diagnostic yield, post-operative complication rate, and mortality rate between VATLB and OLB had no significant difference.
接受OLB 或VATLB 者在诊断率和并发症发生率上无统计学显著差异。
The diagnostic yield, post-operative complication rate, and mortality rate between VATLB and OLB had no significant difference.
接受OLB 或VATLB 者在诊断率和并发症发生率上无统计学显著差异。
应用推荐